Invesco’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-422
Closed -$159K 3890
2020
Q4
$159K Buy
422
+40
+10% +$14K ﹤0.01% 3581
2020
Q3
$117K Sell
382
-11
-3% -$4.21K ﹤0.01% 3560
2020
Q2
$148K Sell
393
-23,490
-98% -$6.65M ﹤0.01% 3540
2020
Q1
$5.44M Sell
23,883
-23,844
-50% -$9.11M ﹤0.01% 1829
2019
Q4
$25.2M Buy
47,727
+109
+0.2% +$59K 0.01% 1290
2019
Q3
$20.5M Sell
47,618
-47
-0.1% -$30.2K 0.01% 1394
2019
Q2
$56.8M Buy
+47,665
New +$57M 0.01% 975
2018
Q2
Sell
-1,178
Closed -$1.91M 3890
2018
Q1
$1.91M Sell
1,178
-617
-34% -$1.28M ﹤0.01% 2622
2017
Q4
$3.01M Buy
+1,795
New +$2.37M ﹤0.01% 2296
2016
Q4
Sell
-1,294
Closed -$925K 3692
2016
Q3
$925K Buy
1,294
+118
+10% +$90.3K ﹤0.01% 2989
2016
Q2
$855K Buy
+1,176
New +$810K ﹤0.01% 2987

Other funds holding CBIO